Skip to main content
. Author manuscript; available in PMC: 2015 Feb 17.
Published in final edited form as: J Pediatr. 2002 Sep;141(3):327–334. doi: 10.1067/mpd.2002.126301

Table III. Effects of cardiac impairment, CHF and/or medications, and CHF on risk of death among group I cohort (Cox regression analysis).

Covariate n (deaths) Estimated β SE P value RR 95% CI
Cardiac impairment 201 (69) 2.137 0.167 < .001 8.5 5.2, 13.9
CHF and/or cardiac medications 201 (69) 2.532 0.250 < .001 12.6 7.8, 20.4
CHF alone* 201 (69) 2.682 0.525 < .001 14.6 8.2, 26.0
*

Risk of death after CHF remained elevated after adjustment for disease severity with CD4 T-cell counts (adjusted relative risk [RR] = 5.7 [95% CI, 3.1-10.3, P < .001]).